Tenet Healthcare Corp. Q1 2007 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2007. Tenet Healthcare Corporation operates 62 general hospitals (including five classified as discontinued operations), a cancer hospital, and a critical access hospital across 12 states, totaling 15,805 licensed beds. The company is executing a turnaround strategy focused on divesting underperforming assets, controlling costs, and improving patient volumes.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Net Operating Revenues | $2,279 million | $2,210 million |
| Operating Income | $98 million | $87 million |
| Net Income | $75 million | $70 million |
| Diluted EPS (Continuing Ops) | $0.20 | $0.00 |
| Cash and Cash Equivalents | $584 million | $975 million (end of period) |
| Long-Term Debt (net of current) | $4,762 million | $4,760 million |
| Net Cash Used in Operating Activities | ($154 million) | ($321 million) |
Liquidity: As of March 31, 2007, Tenet held $584 million in cash and had $616 million in borrowing capacity under its $800 million revolving credit facility. There were no borrowings outstanding under the facility at period end.
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 3.1% year-over-year, driven by improved managed care pricing and higher disproportionate share payments, despite a 1.7% decline in admissions and 3.2% decline in patient days.
- Profitability: Operating income improved to $98 million from $87 million. This was significantly aided by a reduction in impairment and restructuring charges (from $29 million in 2006 to $3 million in 2007) and a $92 million income tax benefit in 2007 compared to a $4 million expense in 2006.
- Discontinued Operations: The company recorded a net loss of $18 million from discontinued operations in Q1 2007, compared to a net income of $69 million in Q1 2006. The prior year included a $45 million insurance recovery related to the Redding Medical Center settlement.
- Cash Flow: Net cash used in operating activities improved significantly to $154 million from $321 million, primarily due to lower payments for restructuring and litigation settlements.
Guidance, Outlook, and Risks
Management Commentary: Management continues to focus on turnaround strategies, including the divestiture of hospitals (recently sold Graduate Hospital and Lindy Boggs real estate; agreed to sell two Pennsylvania hospitals). Capital expenditures for 2007 are projected between $750 million and $800 million.
Accounting Changes: Effective January 1, 2007, Tenet adopted FASB Interpretation No. 48 (FIN 48) regarding uncertainty in income taxes. This resulted in a $178 million cumulative effect adjustment to retained earnings. However, actions taken in Q1 2007 reduced estimated liabilities for uncertain tax positions by $107 million, recognized as a tax benefit.
Risks and Contingencies:
- Legal Proceedings: In April 2007, Tenet settled an SEC investigation regarding Medicare outlier reimbursements and contractual allowances for a $10 million civil penalty. Other pending matters include wage and hour class actions (accrued liability of $21 million), qui tam actions, and disputes regarding lease defaults.
- Bad Debt: High levels of uninsured and underinsured patients continue to pressure the provision for doubtful accounts, which rose to $141 million (6.2% of revenue) from $121 million (5.5% of revenue).
- Volume Decline: Patient volumes remain challenged by competition, physician attrition, and unfavorable publicity from legacy litigation.
Investor Verification Checklist
- Verify the status and expected closing dates of the two Pennsylvania hospital divestitures announced in April 2007.
- Monitor the resolution of the $10 million SEC settlement and the distribution of funds to the "fair fund."
- Track the aging of accounts receivable, specifically the 33% collection rate for self-pay accounts and the impact of the "Compact with Uninsured Patients."
- Review the impact of the FIN 48 adoption on future tax provisions and the $107 million liability reduction recognized in Q1.
- Assess the progress of the "Targeted Growth Initiative" and its effect on reversing volume declines in key markets (California, Florida, Texas).